🚀 VC round data is live in beta, check it out!
AtaiBeckley Valuation Multiples
Discover revenue and EBITDA valuation multiples for AtaiBeckley and similar public comparables like Eli Lilly, Johnson & Johnson, AbbVie, Roche and more.
AtaiBeckley Overview
About AtaiBeckley
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Founded
2020
HQ
Employees
63
Website
Sectors
Financials (FY)
Market Cap
—
AtaiBeckley Stock Performance
AtaiBeckley has current market cap of —.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| — | — | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAtaiBeckley Valuation Multiples
AtaiBeckley Financial Valuation Multiples
As of April 16, 2026, AtaiBeckley has market cap of —.
Equity research analysts estimate AtaiBeckley's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 |
|---|
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified AtaiBeckley Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
AtaiBeckley Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| AtaiBeckley | XXX | XXX | XXX | XXX | XXX | XXX |
| Eli Lilly | XXX | XXX | XXX | XXX | XXX | XXX |
| Johnson & Johnson | XXX | XXX | XXX | XXX | XXX | XXX |
| AbbVie | XXX | XXX | XXX | XXX | XXX | XXX |
| Roche | XXX | XXX | XXX | XXX | XXX | XXX |
| AstraZeneca | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AtaiBeckley M&A Activity
AtaiBeckley acquired XXX companies to date.
Last acquisition by AtaiBeckley was on XXXXXXXX, XXXXX. AtaiBeckley acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by AtaiBeckley
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAtaiBeckley Investment Activity
AtaiBeckley invested in XXX companies to date.
AtaiBeckley made its latest investment on XXXXXXXX, XXXXX. AtaiBeckley invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by AtaiBeckley
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout AtaiBeckley
| When was AtaiBeckley founded? | AtaiBeckley was founded in 2020. |
| Where is AtaiBeckley headquartered? | AtaiBeckley is headquartered in United States. |
| How many employees does AtaiBeckley have? | As of today, AtaiBeckley has over 63 employees. |
| Is AtaiBeckley publicly listed? | Yes, AtaiBeckley is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of AtaiBeckley? | AtaiBeckley trades under 9VC ticker. |
| When did AtaiBeckley go public? | AtaiBeckley went public in 2021. |
| Who are competitors of AtaiBeckley? | AtaiBeckley main competitors are Eli Lilly, Johnson & Johnson, AbbVie, Roche. |
| Is AtaiBeckley profitable? | No, AtaiBeckley is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.